back to Directory

Prokarium

Prokarium logo

Founded
2012
Patents
7
Clinical Trials
2

Prokarium is a privately owned, UK-based biotechnology company with a vision to create targeted vaccines and immunotherapies based on engineered Salmonella strains.


Posts Mentioning This Company

15 Biopharma Research Trends to Watch in 2022

  
Table of contents:    mRNA vaccines and RNA therapies  Epitranscriptomics Targeting RNA with small molecules Deep learning and big data in drug discovery Neoantigens Theranostics  Exosomes Synthetic Biology 3D Bioprinting Antibiotics “anti-trend” (and hope?) Nanotechnologies in Drug Delivery Gene Editing (CRISPR-Cas9) Aging research  Microbiome  Protein Degraders   Discoveries made in …